Genetic modifiers of atherosclerosis in mice

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 11, 2000, Pages 2336-2345

  Knowles, Joshua W ^a   Maeda, Nobuyo ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

ApoE; Diabetes; Hypertension; Inflammation; LDL receptor

Indexed keywords

APOLIPOPROTEIN E; LOW DENSITY LIPOPROTEIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD CLOTTING; BLOOD PRESSURE; DISEASE COURSE; DNA MODIFICATION; FIBRINOLYSIS; GENETIC VARIABILITY; GLUCOSE METABOLISM; HEREDITY; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0033767887     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.11.2336     Document Type: Short Survey

References (115)

1. Atheromata in an inbred strain of mice
2. Variation in susceptibility to atherosclerosis among inbred strains of mice
3. The mouse as a model for human cardiovascular disease and hyperlipidemia
4. Insertion of DNA sequences into the human chromosomal β-globin locus by homologous recombination
5. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells
6. Targeted correction of a mutant HPRT gene in mouse embryonic stem cells
7. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells
8. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells
9. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E
10. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery
11. Gene targeting approaches to complex genetic diseases: Atherosclerosis and essential hypertension
12. Atherosclerosis and the mouse: A decade of experience
13. Mouse models of atherosclerosis
14. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology
15. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree
16. Atherosclerosis in mice lacking apoE: Evaluation of lesional development and progression
17. Diet-induced atherosclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption
18. Effect of aging on aortic expression of the vascular cell adhesion molecule-1 and atherosclerosis in murine models of atherosclerosis
19. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice
20. The pathogenesis of atherosclerosis: Aperspective for the 1990s
21. Ath-1, a gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice
22. Transgenic mouse models to study the role of apoE in hyperlipidemia and atherosclerosis
23. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E
24. Intraperitoneal administration of anti-c-fms monoclonal antibody prevents initial events of atherogenesis but does not reduce the size of advanced lesions in apolipoprotein E-deficient mice
25. P-selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E- deficient mice
26. Absence of P-selectin delays fatty streak formation in mice
27. The combined role of P- and E-selectins in atherosclerosis
28. Deficiency of inflammatory cell adhesion molecules protects against atherosclerosis in mice
29. Chemokines and atherosclerosis
30. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice
31. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis
32. Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice
33. Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice
34. Accelerated atherosclerosis in mice lacking tumor necrosis factor receptor p55
35. T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse
36. The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice
37. Reduction of atherosclerosis in mice by inhibition of CD40 signalling
38. Requirement for CD154 in the progression of atherosclerosis
39. IFN-γ potentiates atherosclerosis in ApoE knock-out mice
40. Steering committee of the Physicians' Health Study Research Group
41. Efficacy of ticlopidine and aspirin for prevention of reversible cerebrovascular ischemic events: The Ticlopidine Aspirin Stroke Study
42. Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apoE-deficient mice
43. Role of group II secretory phospholipase A2 in atherosclerosis, 1: Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2
44. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2
45. A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice
46. Five-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects
47. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women
48. Diabetes and cardiovascular disease: The Framingham Study
49. Diabetes and cardiovascular disease
50. Hyperglycemia and the pathogenesis of atherosclerosis: Lessons from murine models
51. RAGE: A novel cellular receptor for advanced glycation end products
52. Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins
53. Effect of streptozotocin-induced hyperglycemia on lipid profiles, formation of advanced glycation endproducts in lesions, and extent of atherosclerosis in LDL receptor-deficient mice
54. Accelerated atherosclerosis and premature calcified cartilaginous metaplasia in the aorta of diabetic male ApoE knockout mice can be prevented by chronic treatment with 17β-estradiol
55. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts
56. Increased atherosclerosis in streptozotocin-induced diabetic mice
57. C57BL/6 mice fed high fat diets as models for diabetes-accelerated atherosclerosis
58. Genetic analysis of glucose tolerance in inbred mouse strains: Evidence for polygenic control
59. Diabetes: The genetic connections
60. Disruption of IRS-2 causes type 2 diabetes in mice
61. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene
62. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1
63. Alternative pathway of insulin signalling in mice with targeted disruption of the JRS-1 gene
64. Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles
65. Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2
66. GLUT4 heterozygous knockout mice develop muscle insulin resistance and diabetes
67. Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substrate-1
68. Vascular endothelium, hemodynamic forces, and atherogenesis
69. Does hypertension predispose to coronary disease? Conflicting epidemiological and experimental evidence
70. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: The Heart Outcomes Prevention Evaluation Study Investigators
71. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the Systolic Hypertension in the Elderly Program (SHEP): SHEP Cooperative Research Group
72. Effect of coarctation on matrix content of experimental aortic atherosclerosis: Relation to location, plaque size and blood pressure
73. Effects of chronic aortic coarctation on atherosclerosis and arterial lipid accumulation in the Watanabe hereditary hyperlipidemic (WHHL) rabbit
74. Influence of hypertension on aortic atherosclerosis in the Watanabe rabbit
75. Exacerbation of atherosclerosis by hypertension. Potential mechanisms and clinical implications
76. Angiotensin II atherogenicity in apolipoprotein E deficient mice is associated with increased cellular cholesterol biosynthesis
77. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits
78. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice
79. L-Arginine prevents xanthoma development and inhibits atherosclerosis in LDL receptor knockout mice
80. Antiatherosclerotic and antioxidative effects of captopril in apolipoprotein E-deficient mice
81. The angiotensin-II receptor antagonist, losartan, inhibits LDL lipid peroxidation and atherosclerosis in apolipoprotein E-deficient mice
82. α1-Adrenergic plus angiotensin receptor blockade reduces atherosclerosis in apolipoprotein E-deficient mice
83. Enhanced atherosclerosis and kidney dysfunction in eNOS(-/-)ApoE(-/-) mice are ameliorated by enalapril treatment
84. Acceleration of atherosclerotic lesions in transgenic mice with hypertension by the activated renin-angiotensin system
85. The L-arginine-nitric oxide pathway
86. Pressure-induced arterial wall stress and atherosclerosis
87. The role of fluid mechanics in the localization and detection of atherosclerosis
88. Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction
89. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction
90. A DNA variant at the angiotensin-converting enzyme gene locus associates with coronary artery disease in the Caerphilly Heart Study
91. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease
92. Angiotensin-converting enzyme gene and atherosclerosis
93. On the importance of quantitative genetic variations in the etiology of hypertension
94. Fibrinogen as a cardiovascular risk factor: A metaanalysis and review of the literature
95. Fibrinogen deficiency is compatible with the development of atherosclerosis in mice
96. Fibrinogen deficiency reduces vascular accumulation of apolipoprotein(a) and development of atherosclerosis in apolipoprotein(a) transgenic mice
97. Impaired fibrinolysis in coronary artery disease
98. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris: European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group
99. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction
100. Atherosclerosis progression in LDL receptor-deficient and apolipoprotein E-deficient mice is independent of genetic alterations in plasminogen activator inhibitor-1
101. Plasminogen deficiency accelerates vessel wall disease in mice predisposed to atherosclerosis
102. Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice
103. Mouse systems for studying the genetics of hypertension and related disorders
104. Genetic background determines the extent of atherosclerosis in apoE-deficient mice
105. Determinants of atherosclerosis susceptibility in the C3H and C57BL/6 mouse model: Evidence for involvement of endothelial cells but not blood cells or cholesterol metabolism
106. Spontaneously hyperlipidemic (SHL) mice: Japanese wild mice with apolipoprotein E deficiency
107. Strategies for studying cardiovascular phenotypes in genetically manipulated mice
108. A common variant of the endothelial nitric oxide synthase (Glu298→Asp) is a major risk factor for coronary artery disease in the UK
109. The apolipoprotein E polymorphism: A comparison of allele frequencies and effects in nine populations
110. Targeted replacement of the mouse apolipoprotein E gene with the common human apoE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis
111. ApoE structure determines VLDL clearance and atherosclerosis risk in mice
112. Mice cloned from embryonic stem cells
113. Generation of mice from wild-type and targeted ES cells by nuclear cloning